Specialty Retailers In The Earnings Spotlight: Lululemon, Michaels, Restoration Hardware
- Three specialty retailers are expected to share their latest quarterly results this week.
- Consensus forecasts from Wall Street analysts call for top-line growth from all three of them.
- However, only one is expected to offer growth in earnings, relative to the year-ago period.
In the lull between one earnings season and another, only a sprinkling of off-season report are on the schedule for this week. Among the few anticipated reports will be the latest quarterly results from three top specialty retailers.
The Wall Street forecasts call for top-line growth from all three, but unlike for arts and craft store operator Michaels Companies Inc (NASDAQ: MIK), earnings declines are predicted from athletic apparel purveyor Lululemon Athletica inc. (NASDAQ: LULU) and for home furnishings retailer Restoration Hardware Holdings Inc (NYSE: RH).
Below is a quick look at what's expected from the reports of these three retailers, as well as a peek at some of other companies that also are on tap to post quarterly results this week.
In its report early Wednesday, this retailer of yoga apparel and accessories is expected to say that in its fiscal first quarter it had earnings of $0.32 per share, according to 89 Estimize respondents. That would be $0.02 less than in the same period of last year. The Wall Street consensus estimate is just $0.31 per share, but note that the analysts underestimated EPS by a nickel in the previous quarter.
The Estimize revenue estimates were less than the posted results in the previous quarter, and this time the respondents are looking for about $488.12 million. The Wall Street revenue forecast is $487.69 million. Either estimate would be more than 15 percent higher than in the same period of last year.
The consensus Wall Street forecast calls for this leading operator of arts and crafts stores to post fiscal first-quarter earnings of $1.22 per share (which would be more than 8 percent higher than in the year-ago period) and for revenue to have risen nearly 8 percent to $1.17 billion in the period.
Note that EPS topped consensus expectations in the previous three quarters by a penny or two. The 14 analysts surveyed seem pretty certain, as the consensus earnings estimate has not changed in the past 60 days, and the individual estimates only range from $0.34 to $0.36. Estimize has no consensus forecast for Michaels, which is scheduled to share its latest results before Tuesday's opening bell.
The fiscal first-quarter profit of this home-furnishings retailer is predicted to have plunged to $0.05 per share, according to both Wall Street analysts and the consensus of 13 Estimize respondents, from the $0.23 reported a year ago. Note that earnings fell well short of expectations back in the fourth quarter.
In Wednesday afternoon's report, analysts are looking for $452.86 million in revenue. Estimize is somewhat more optimistic, with a forecast of $466.01 million for the three months that ended in April. Revenue also fell well short of expectations in the previous quarter. So far, Wall Street anticipates sequential and year-over-year revenue growth in the current period, as well as per-share earnings of $0.80.
Other companies that Wall Street analysts expect to show at least some earnings growth when they post there latest results this week include Casey's General Stores, HD Supply, H&R Block, J.M. Smucker, Thor Industries, Vail Resorts and VeriFone Systems.
The EPS at Tailored Brands, United Natural Foods, Valeant Pharmaceuticals and Verint Systems will be smaller than a year ago, if analysts' expectations are on target. And the consensus forecasts call for net losses from Mattress Firm and Navistar.
In the following week, watch for the latest results from the likes of Kroger, Oracle and Rite Aid.
At the time of this writing, the author had no position in the mentioned equities.
Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.